These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. High-dose megestrol acetate. A possible treatment for cachexia. Tchekmedyian NS; Tait N; Moody M; Aisner J JAMA; 1987 Mar; 257(9):1195-8. PubMed ID: 3806918 [TBL] [Abstract][Full Text] [Related]
8. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. Gebbia V; Testa A; Gebbia N Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133 [TBL] [Abstract][Full Text] [Related]
9. Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection. von Roenn JH; Murphy RL; Weber KM; Williams LM; Weitzman SA Ann Intern Med; 1988 Nov; 109(10):840-1. PubMed ID: 3190032 [No Abstract] [Full Text] [Related]
10. Appetite stimulation with megestrol acetate in cachectic cancer patients. Tchekmedyian NS; Tait N; Moody M; Greco FA; Aisner J Semin Oncol; 1986 Dec; 13(4 Suppl 4):37-43. PubMed ID: 3798127 [TBL] [Abstract][Full Text] [Related]
14. The Bristol-Myers Anorexia/Cachexia Recovery Instrument (BACRI): a brief assessment of patients' subjective response to treatment for anorexia/cachexia. Cella DF; VonRoenn J; Lloyd S; Browder HP Qual Life Res; 1995 Jun; 4(3):221-31. PubMed ID: 7613532 [TBL] [Abstract][Full Text] [Related]
15. Treatment of anorexia and weight loss with megestrol acetate in patients with cancer or acquired immunodeficiency syndrome. Tchekmedyian NS; Hickman M; Heber D Semin Oncol; 1991 Feb; 18(1 Suppl 2):35-42. PubMed ID: 1992535 [TBL] [Abstract][Full Text] [Related]